KIF18A and lung adenocarcinoma: To explore the possible regulatory mechanism underlying KIF18A affecting the progression of lung adenocarcinoma, the shRNA plasmids specifically targeting KIF18A were transfected into 2 types of human lung adenocarcinoma cells, A549 and H1975 cells, to block its expression.